Skip to content

Comparison of laser ablation and chemical ablation in facial verruca plana

Efficacy and safety of erbium YAG laser vs salicylic acid and lactic acid flexible collodion paint in facial verruca plana: a comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048379
Enrollment
80
Registered
2022-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Erbium YAG laser and Salicylic acid and lactic acid flexible collodion paint in facial verruca plana: Er:YAG laser with the wavelength of 2940 nm spot size varying from 3 to 9mm fluence

Sponsors

Sardar Patel medical college, Bikaner, Rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of facial verruca plana with at least four or more than four lesions, Age 12 to 65 years

Exclusion criteria

Exclusion criteria: Immunodeficiency pregnancy and breastfeeding history of hypertrophic scars or keloids recurrent herpes infection active secondary bacterial infection photosensitivity retinoid use within the last 6 months collagen vascular disease undergoing any other medical treatment within the last three months.

Design outcomes

Primary

MeasureTime frame
The clinical response will be compared based on the clearance of lesions as complete (100% lesion clearance), excellent (75â??99%), good (50â??75%), or poor ( 50% )Timepoint: at the end of 3 months

Secondary

MeasureTime frame
Adverse effects and recurrence rateTimepoint: at the end of 3 months

Countries

India

Contacts

Public ContactAakanksha Arora

Sardar Patel Medcal College, Bikaner

akarora357@gmail.com09991065569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026